Norfolk and Suffolk mental health trust exits special measures
A mental health trust that was once the worst performing in the country has been removed from its "special measures" status after more than seven years, following improvements.The Norfolk and Suffolk NHS Foundation Trust (NSFT) said it had exited the Recovery Support Programme that helps failing providers. The decision followed a period of sustained improvement, said NHS England, and the trust's chair Zoe Billingham said it had "achieved stability".However, campaigners for better mental health care have questioned the decision.
The trust, which is headquartered in Hellesdon, Norwich, was the first of its type to receive extra support back in 2015 when it was placed in "special measures" - the precursor to the Recovery Support Programme.This grade was removed the following year, but the trust returned to special measures in 2017 because of its poor performance.NSFT had been rated "inadequate" on four occasions in eight years by Care Quality Commission (CQC) inspectors, with its most recent rating in February 2023 stating it "requires improvement".
Ms Billingham said: "We have now achieved stability; we have a clear plan; the means for delivery; and the belief that we can change NSFT once and for all, for the better."Caroline Donovan, chief executive at the trust, added: "There truly is so much that has been achieved by everyone last year and so much to feel optimistic about in 2025."We can see the impact on service users already, with more positive comments about our services; our friends and family test results have improved; waiting times have significantly reduced in some areas; and our performance is improving."NSFT will move from mandated national intensive support to mandated regional support and oversight.Clare Panniker, regional director for NHS England, said it was "positive news" for patients, but there was still much work to do. "NHS England will ensure that these improvements are built upon at pace to further improve the service NSFT provide," she said.
Chair of the NSFT Crisis Campaign, Mark Harrison, said: "The campaign has no confidence in NHS England as they have presided over 12 years of failing mental health services."We don't understand how NSFT can be released from the Recovery Support Programme ahead of an independent inspection from the CQC."The CQC said NHS England could include its previous reports when removing trusts from the programme. NSFT said it had completed 100% of the CQCs "must do" actions.
The trust said it reviewed 12,503 deaths that had occurred between April 2019 to April 2023, and found just over 420 people died from unexplained unnatural deaths during this period.There are no national mortality figures for England to compare the figure to.It also "believes that NSFT are not an outlier across mental health trusts throughout the country".Of the unexplained unnatural deaths, the predominate demographic is males between the ages of 40 to 50.
In a joint statement, the Labour MPs for Norwich North and Ipswich, Alice Macdonald and Jack Abbott, said: "For the best part of a decade, the Norfolk and Suffolk NHS Foundation Trust has failed thousands of people, with terrible consequences."This news that NSFT has left special measures marks some welcome progress, but the challenge for NSFT is now to ensure this is a first step towards sustained, long-term improvement."The statement continued: "It remains the case that many people in our region are yet to feel this progress in their lived experience of mental health care, with many still recounting tragic personal stories of institutional failure."
Follow Norfolk news on BBC Sounds, Facebook, Instagram and X.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Western Telegraph
6 hours ago
- Western Telegraph
Medical staff who responded to Southport knife attacks honoured by King
Paul Smith, a senior paramedic team leader, treated victims at the scene where Bebe King, six, Elsie Dot Stancombe, seven, and Alice Dasilva Aguiar, nine, were murdered and 10 others injured at a Taylor Swift-themed dance class last July. Mr Smith, who works for the North West Ambulance Service, was awarded a British Empire Medal (BEM) for his services to the community in Merseyside after 'he put the needs of the injured before his own safety', the NHS said. I'd like to recognise those staff who were involved in the response to the knife attack in Southport last summer. These awards rightly honour their incredible dedication and commitment in an awful situation Sir Jim Mackey, NHS chief executive Dr George Bramham, who was also a first responder, received the same honour. Martin Johnson and Elizabeth Parsons, who were part of the surgical team in theatre who treated people sent to Southport Hospital after the stabbings, have been given the same medals. Sir Jim Mackey, NHS chief executive, praised the staff for their 'incredible dedication and commitment in an awful situation'. Meanwhile, Reverend Martin Abrams, a spiritual care and chaplaincy manager, has been made a Member of the Order of the British Empire (MBE) for services to the community in Merseyside and west Lancashire. This stands as a legacy of the work to address health inequalities by driving forward a powerful vision of exceptional quality healthcare for all, ensuring equitable access, excellent experience and optimal outcomes Professor Bola Owolabi, NHS England He played a key role in the community after the horrors of the attacks, the health service said. Other NHS staff receiving honours include Professor Bola Owolabi, a GP and director of inequalities at NHS England, who was made a Commander of the Order of the British Empire (CBE) for her services to reducing health inequalities. Professor Owolabi said: 'This stands as a legacy of the work to address health inequalities by driving forward a powerful vision of exceptional quality healthcare for all, ensuring equitable access, excellent experience and optimal outcomes.' Sir Jim added: 'I want to give my heartfelt congratulations to all the people working in the NHS that have received honours, who work tirelessly everyday to care for their patients. 'I'd also like to recognise those staff who were involved in the response to the knife attack in Southport last summer. These awards rightly honour their incredible dedication and commitment in an awful situation. 'The NHS is made up of highly committed and dedicated people that work hard to give the best possible care to patients, and these honours recognise their skill, compassion and bravery.'
ITV News
15 hours ago
- ITV News
World-first 'Trojan horse' drug to be given to blood cancer patients in England
Blood cancer patients in England will be among the first in the world to have access to a new 'Trojan horse' treatment, health officials have announced. Studies suggest the targeted therapy can stop myeloma from progressing by nearly three times as long as existing treatments. It is estimated that around 1,500 patients a year with multiple myeloma – an incurable cancer of the bone marrow – will benefit from the treatment. It comes after the National Institute for Health and Care Excellence (Nice) approved belantamab mafodotin, also known as Blenrep and made by GlaxoSmithKline, for NHS use. NHS England said that it is the first health system in the world to roll out the treatment. Officials said that the drug can now be offered to patients whose cancer has progressed or has not responded to another first-line treatment. The treatment, which is given as an infusion every three weeks along with other cancer drugs, is a type of antibody drug which targets and attaches to cancer cells. It has been dubbed a 'Trojan horse' treatment because it works by being taken into a cancer cell, before releasing a high concentration of a lethal molecule to destroy the cell from inside. 'Myeloma is an aggressive type of blood cancer, but we have seen a steady improvement in the outlook for patients over recent years as we have introduced new targeted therapies,' Professor Peter Johnson, NHS England's national clinical director for cancer, said. 'I am delighted that patients in England will be the first to benefit from this new treatment, which has the potential to keep cancer at bay for years longer, giving people the chance of more precious time with friends and family. 'This treatment could be life-changing for many patients and their families, and that's why it is so important that the NHS continues to secure quick access to the latest, innovative treatments like this, at affordable prices to the taxpayer.' Helen Knight, director of medicines evaluation at Nice, said: 'We're delighted that people in the UK will become among the first in the world to access belantamab mafodotin for this indication. 'This recommendation demonstrates our commitment to getting the best care to patients fast, while ensuring value for the taxpayer.' Trials have suggested that the treatment, in combination with bortezomib and dexamethasone, delayed progression of the disease by an average of three years, compared to just over a year for patients taking commonly used drug daratumumab along with the other treatments. Patient Paul Silvester, 60, from Sheffield, was diagnosed with myeloma in July 2023 and received treatment at the Royal Hallamshire Hospital. The first treatment he was given failed to stop his cancer from progressing so he was given belantamab mafodotin through an early access programme. 'I feel like this treatment has brought the party balloons back in the house. It has been amazing – within the first two or three weeks, after the first dose, I was in remission,' he said. 'It gives me quite a lot of confidence in the drugs and it makes me more optimistic about the future.'I've been feeling well and I'm still quite active – that's what's important in terms of your quality of life. 'One of my daughters is graduating from university in October and it's a goal for me to be there.' Shelagh McKinlay, director of research and advocacy at blood cancer charity Myeloma UK, said: 'It's fantastic to see the UK at the forefront of myeloma treatment. 'We have been working very hard for the last year to get this treatment approved and we know it will transform the lives of thousands of people with myeloma.' Health Minister Karin Smyth said: 'This groundbreaking therapy puts the NHS at the forefront of cancer innovation.'By harnessing cutting-edge 'trojan horse' technology, we're offering new hope to blood cancer patients across the country.'
Scottish Sun
16 hours ago
- Scottish Sun
Ozempic-like weight loss jabs could one day be dished out like statins, says top NHS doctor
Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) WEIGHT loss jabs could one day be dished out like statins, England's top doctor says. Professor Sir Stephen Powis, medical director of NHS England, said in years to come they will get cheaper and may be used to prevent a range of illnesses. 1 NHS' top doctor says weight loss jabs like Mounjaro "will become more widespread" Credit: Alamy But chief medical officer Professor Sir Chris Whitty said they are 'not a get out of jail card' and people must still try to be healthy. GPs will roll out Mounjaro across the country from this month. The injections currently cost the NHS around £100 each but prices are expected to drop over time. Research increasingly shows they have health benefits beyond diabetes and weight loss, potentially including reducing the risks of cancer, dementia and heart diseases. These are not get-out-of-jail cards Professor Sir Chris Whitty Cholesterol-lowering statins have been used for decades to reduce heart attacks and strokes and now cost next to nothing at 3p a pill. Studies suggest they also reduce the risk of dementia, though it is not what they were designed for. Prof Powis said: 'The use of statins is now very different from when they first came out and I've no doubt that will be the same for these drugs. 'I think over time it's highly likely that they will become more widespread. 'I think there will be a combination of increased evidence of positive outcomes and costs dropping, and we will learn better how to deploy them. 'It's not completely unusual for drugs over time to be found to have effects that go over and beyond what they were initially designed for. 'I am not starry-eyed about weight loss drugs but it's very exciting. 'We're in the foothills of learning how to use them.' NHS prescriptions surging NHS use of the jabs is already skyrocketing and official figures show prescriptions in England surged from 1.4million in 2023 to 2.7m in 2024. Doctors spent a total of £269million on them in the latest financial year and more than a million people are estimated to be buying them privately. Prof Whitty said it is important for people to still get help to eat healthily and exercise, as well as taking medicine. He added: 'These are not get out of jail cards. 'What we shouldn't do is use it as an excuse, as a society, not to deal with what is a rising and very serious problem.'
